Source:http://linkedlifedata.com/resource/pubmed/id/16395268
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
2006-4-13
|
pubmed:abstractText |
Although clearance of beta(2)-microglobulin is greater with hemodiafiltration than with high-flux hemodialysis, beta(2)-microglobulin concentrations after long-term hemodiafiltration are only slightly less than those obtained with high-flux hemodialysis. Resistance to beta(2)-microglobulin transfer between body compartments could explain this observation. beta(2)-Microglobulin kinetics were determined in patients receiving on-line post-dilution hemodiafiltration for 4 h with 18 l of filtration. Plasma beta(2)-microglobulin concentrations were measured during and for 2 h following hemodiafiltration and immediately before the next treatment. The filter clearance of beta(2)-microglobulin was determined from arterial and venous concentrations. The beta(2)-microglobulin generation rate was calculated from the change in the plasma concentration between treatments. The intercompartmental clearance was obtained by fitting the observed concentrations to a two-compartment, variable volume model. The plasma clearance of beta(2)-microglobulin by the filter was 73 +/- 2 ml/min. Plasma beta(2)-microglobulin concentrations decreased by 68 +/- 2% from pre- to post-treatment (27.1 +/- 2.2-8.5 +/- 0.7 mg/l), but rebounded by 32+/-3% over the next 90 min. The generation rate of beta(2)-microglobulin was 0.136 +/- 0.008 mg/min. The model fit yielded an intercompartmental clearance of 82 +/- 7 ml/min and a volume of distribution of 10.2 +/- 0.6 l, corresponding to 14.3 +/- 0.7% of body weight. Hemodiafiltration provides a beta(2)-microglobulin clearance of similar magnitude to the intercompartmental clearance within the body. As a result, intercompartmental mass transfer limits beta(2)-microglobulin removal by hemodiafiltration. This finding suggests that alternative strategies, such as increased treatment times or frequency of treatment, are needed to further reduce plasma beta(2)-microglobulin concentrations.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0085-2538
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
69
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1431-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16395268-Adult,
pubmed-meshheading:16395268-Aged,
pubmed-meshheading:16395268-Body Fluid Compartments,
pubmed-meshheading:16395268-Body Weight,
pubmed-meshheading:16395268-Female,
pubmed-meshheading:16395268-Hemodiafiltration,
pubmed-meshheading:16395268-Hemodialysis Solutions,
pubmed-meshheading:16395268-Humans,
pubmed-meshheading:16395268-Kinetics,
pubmed-meshheading:16395268-Male,
pubmed-meshheading:16395268-Middle Aged,
pubmed-meshheading:16395268-Models, Biological,
pubmed-meshheading:16395268-beta 2-Microglobulin
|
pubmed:year |
2006
|
pubmed:articleTitle |
Resistance to intercompartmental mass transfer limits beta2-microglobulin removal by post-dilution hemodiafiltration.
|
pubmed:affiliation |
Department of Medicine, University of Louisville, Kentucky 40202-1718, USA. richard.ward@kdp.louisville.edu
|
pubmed:publicationType |
Journal Article,
Comparative Study
|